Publicacions

Esteu aquí

Home » Research Groups » Dianes moleculars del Càncer » Publicacions

Dianes moleculars del Càncer

Key contribution of CPEB4-mediated translational control to cancer progression, Nature Medicine

Ortiz-Zapater E, Pineda D, Martínez-Bosch N, Iglesias M, Alameda F,Moreno M, Eliscovich C, Eyras E, Real FX, Méndez R and Navarro P,
2011

Galectin-1 is a novel functional receptor for tissue plasminogen activator in pancreatic cancer.

Roda O, Ortiz-Zapater E, Martínez-Bosch N, Gutiérrez-Gallego R, Vila-Perelló M, Ampurdanés C, Gabius HJ, André S, Andreu D, Real FX and Navarro P.,
2009

Tissue plasminogen activator induces pancreas cancer cell proliferation by a non-catalytic mechanism that requires ERK1/2 activation through Epidermal Growth Factor Receptor and Annexin A2

Ortiz-Zapater E, Peiro S, Roda O, Corominas JM, Aguilar S, Ampurdanes C, Real FX and Navarro P,
2007

Tissue plasminogen activator mediates amyloid induced neurotoxicity via sustained Erk1/2 activation.

Medina MG, Ledesma, MD, Dominguez JE, Medina M, Zagra D, Alameda F, Dotti CG and Navarro P. ,
2005

The tissue plasminogen activator system in murine exocrine pancreas cancer:selective expression in ductal tumors and contribution to cancer progression.

Aguilar S, Corominas JM, Malats N, Dufresne M, Real FX and Navarro P,
2004

New insights into the tPA-Annexin A2 interaction: is Annexin A2 Cys8 the sole requirement for this association?

Roda O, Valero ML, Peiró S, Andreu D, Real FX and Navarro P,
2003

Pàgines